Use of insulin glargine in children under age 6 with type 1 diabetes.

@article{Dixon2005UseOI,
  title={Use of insulin glargine in children under age 6 with type 1 diabetes.},
  author={Brenner F. Dixon and H Peter Chase and Jonathan Burdick and Rosanna V Fiallo-Scharer and Philippe Walravens and Georgeanna Jones Klingensmith and Marian Rewers and S. K. Garg},
  journal={Pediatric diabetes},
  year={2005},
  volume={6 3},
  pages={150-4}
}
AIM Children under 6 yr have the highest incidence of severe hypoglycemia (SH) and the greatest likelihood of brain damage from SH. The purpose of this study is to evaluate the use of insulin glargine (Lantus in children under age 6 with type 1 diabetes (T1D). METHODS The electronic medical records were reviewed for patients under age 6 during the first 6 months of insulin glargine therapy and compared with age, sex, and duration of diabetes for matched control patients on neutral protamine… CONTINUE READING
14 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

Similar Papers

Loading similar papers…